Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
Health Care & Insurance
Articles
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Obamacare shovels another $122M to Indiana insurers
The money, known as reinsurance payments, helped MDwise, Anthem, Humana, Assurant and the Physicians Health Plan of Northern Indiana keep a lid on their losses even as lots of new patients with expensive or untreated medical conditions migrated into the private insurance market.
Aetna-Humana deal could push Cigna to take Anthem offer
With Aetna Inc. and Humana Inc. agreeing to a $37 billion merger, pressure is mounting on the other major health insurers, including Cigna Corp. and Anthem Inc., to make their own deals.
Resurgence of Eli Lilly is touching all corners of region
Central Indiana's economy is diverse, but Lilly is such a behemoth that its ups and downs reverberate statewide.
Community Health to pay $20M to settle false claims charges
The Indianapolis-based hospital system has agreed to pay $20.3 million to settle claims that it overbilled the Medicare and Medicaid programs.
No way out for employers on health benefits
Last week’s Supreme Court ruling upholding the tax credits for Obamacare is just the latest in a string of developments that have kept employers from ditching their group health plans, as many predicted they would.
Acquisition to nearly double OneAmerica’s retirement business
OneAmerica’s purchase of the U.S. retirement business of BMO Financial Corp. will add $26 billion in retirement assets to the $30 billion OneAmerica already manages.
Supreme Court’s Obamacare ruling is a win for Republicans—they just can’t see it
For at least 20 years, Republicans have been pushing for giving tax credits to help individuals buy health insurance. The Supreme Court’s latest Obamacare ruling does Republicans the favor of preserving them.
Huntington leaving IPL’s top job to join OneAmerica
Kelly Huntington, president and CEO of Indianapolis Power & Light Co., has stepped down to become senior vice president of enterprise strategy at OneAmerica Financial Partners Inc., the companies announced Thursday.
London mayor discussing $16B biotech fund with Lilly, others
London Mayor Boris Johnson is proposing a $16 billion fund to encourage growth of emerging health-care companies in the United Kingdom in an effort to catch up to biotechnology clusters in the United States.
British court ruling backs patent protecting Lilly’s Alimta
Eli Lilly and Co. received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Lilly facing first trials over Cymbalta withdrawal symptoms
Eli Lilly and Co. has been ordered to face claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta in the first cases slated to be heard by juries.
CNO finance chief resigns to take Aflac job
CFO Fred J. Crawford joined CNO Financial Group in 2012 and is credited with helping turn around the insurance holding company.
Zimmer, Biomet complete $13.35 billion merger
The Indiana-based company has taken the name Zimmer Biomet Holdings Inc. and will trade under the ticker symbol to "ZBH" on Monday. Zimmer Holdings Inc. agreed to buy privately-held Biomet in April 2014.
Health insurers that win merger race likely to get regulatory OK
A victory by Anthem Inc. in its bid to buy Cigna Corp. could create regulatory hurdles for other insurers exploring deals as antitrust officials seek to hold the line on rising health care costs.
Groups estimate 160,000 Hoosiers could lose subsidies
About 160,000 low- and moderate-income Indiana residents could lose health insurance premium subsidies provided under the Affordable Care Act if the U.S. Supreme Court rules them illegal, two groups estimated Tuesday.
Potential Anthem-Cigna deal hinges on CEO cooperation
Cigna Corp. and Anthem Inc. are poised to do the biggest deal that the health insurance industry has ever seen—if their CEOs can get along.
Lilly drug regimen costing $9,200 a month scores zero in study
In a new scoring system for oncology drugs, a leading group of U.S. cancer doctors awarded a zero for overall benefit to a regimen featuring Alimta, Eli Lilly and Co.’s top-selling product.
Cigna: Anthem’s baggage makes marriage risky
Cigna said Anthem’s a risky bet due to fallout from its massive data breach, lawsuits that accuse it of conspiring to inflate prices, and lack of a growth strategy. But Wall Street thinks this deal is going to happen, unless Cigna can find another buyer.